Phase 1 Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a healthy volunteer (the trial aims for an equal number of men and women, and if you drop out, you would be replaced by someone of the same sex)
- You are between 18 and 45 years old
- If you are male, you weigh at least 50kg; if you are female, you weigh at least 45kg; and your BMI (a measure of body weight relative to height) is between 19 and 26
- You have passed a full health check-up covering things like blood tests, urine tests, heart tracing (ECG), liver and kidney function, checks for infections like hepatitis B, hepatitis C, HIV and syphilis, a chest X-ray, an abdominal scan, and tests for nicotine, drugs, and alcohol — with no significant health concerns found
- You fully understand what the trial involves, including its possible benefits and risks, and are willing to sign a consent form and follow all study requirements
Who may not be able to join:
- You have taken part in another clinical trial within the last 3 months
- Your blood test results show that your liver function markers (ALT, AST, or bilirubin) are above the normal range
- You have an existing liver condition, such as chronic hepatitis B or C, alcoholic liver disease, significant fatty liver disease, or cirrhosis (confirm with trial site)
- You have any condition affecting your heart, liver, kidneys, hormones, digestion, immune system, lungs, nerves, or mental health — including cardiovascular disease, bowel conditions that affect how you absorb medicines, active bleeding (such as stomach ulcers), epilepsy, severe allergic skin or breathing conditions, or active tuberculosis
- You have a history of allergies to any medicines, foods, or skin-related allergens
- You have taken any medicines in the 28 days before the trial that are known to affect how the liver processes drugs — including certain antibiotics, antifungals, anti-seizure medicines, steroids, or other specific drugs (confirm the full list with the trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 027-85726085
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Single dose:PK parameters: Cmax; Single dose:PK parameters: Tmax; Single dose:PK parameters: AUC0-t; Single dose:PK parameters: AUC0-∞; Single dose:PK parameters: t1/2; Single dose:PK parameters: λz; Single dose:PK parameters: Vz/F; Single dose:PK parameters: CL/F; Single dose:PK parameters: AUC_%Extrap; Single dose:PK parameters: MRT; Single dose:PK parameters: Ae_u (t1-t2); Single dose:PK parameters: Ae_u (0-t); Single dose:PK parameters: Rate_u (max); Single dose:PK parameters:Fe_u (0-t); Multiple administration: PK parameters:Cmax,ss; Multiple administration: PK parameters:Tmax,ss; Multipl...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.